Site participation in ANDA-L

Site participation in ANDA

ANDA welcomes participation from all diabetes centres including primary, secondary and tertiary care.

ANDA provides annual, individualised data and quality reports to sites to allow them to benchmark their own performance against other participating centres. This provides health services a unique opportunity to identify strengths and weaknesses in the services they provide.

Participating sites are also provided with access to the data they provide and can use this for their own quality audits, research and/or reporting.

Ethics and research governance

Central Human Research and Ethics Committee (HREC) approval of the ANDA protocol and related documentation has been obtained from Monash Health.

National Research and Evaluation Ethics Committee (NREEC) approval of the ANDA protocol has also been obtained from the Royal Australian College of General Practitioners (RACGP).

Every diabetes centre should seek advice regarding local ethics requirements prior to commencing data collection.

The ANDA Project team can assist with compilation of HREC applications. This will ensure that the HREC approval and ethical requirements remain consistent across participating ANDA sites.

Some sites’ HREC may acknowledge previous approval from a recognised HREC without having an application fully reviewed by a full HREC committee at a scheduled meeting.

How to participate

To contribute to ANDA, diabetes centres must nominate a local site lead. The site lead is responsible for centre participation and compliance with ANDA policies and procedures. Please refer to policies and procedures link.

Diabetes centres are required to register their participation with the ANDA Secretariat to proceed with data collection. They will be given access to the ANDA User documents for assistance in collecting data.

Measuring quality of care

ANDA has adopted a number of key performance indicators to monitor and benchmark the performance of health services providing diabetes care.

Such indicators reported for the 2 data collection modules of ANDA are:

• Diabetes type
• Diabetes management
• Blood glucose control
• Blood pressure
• Height, weight
• Smoking status
• Lipids
• Kidney function
• Complications
• Comorbidities
• Health professional attendances
• Patient self-care practices
• Quality of life assessment

ANDA reporting

ANDA produces two annual reports:

1. Individualised aggregate site reports
2. Pooled aggregate national reports approved by the Australian Government Department of Health.

Reporting periods are consistent so that sites can compare their current performance against previous reporting periods and also use this information for the benefit of benchmarking and quality improvement.

-

Site participation in ANDA-L

What is ANDA-L?

ANDA-L is an extension of ANDA and welcomes participation from all diabetes centres. Its main focus is to prospectively follow up the same cohort of patients attending diabetes centres over a 2–4 year period.

This allows diabetes centres to observe changes in clinical indicators for people with diabetes at both a group and individual level offering a rich source of understanding of treatments and clinical outcomes for people with diabetes.

ANDA-L will provide longitudinal descriptive reporting to all treating centres for quality improvement, which provides a unique opportunity to identify strengths and weaknesses in the services provided.

ANDA-L: Ethics and Research Governance

ANDA-L has received National Mutual Acceptance HREC approval from the Monash Health Human Research Ethics Committee and registered with the Monash University Human Research Ethics Committee.

Each participating site is required to obtain local research governance authorisation prior to commencing data collection. Should they not have a local Research Governance Office, authorisation is required from their local ethics committee.

ANDA-L: Getting started

Once initial contact has been made, the ANDA-L Secretariat will advise your centre on how to begin preparing for ANDA-L data collection. ANDA-L Central Management will help coordinate application submissions for ethical and governance approval. ANDA-L will provide all necessary resources to assist and train all relevant staff prior to data collection commencing.

There are three stages of setting up your diabetes centres as a site for ANDA-L participation:

1. Engagement of relevant site staff, departments and administration
2. Human Research Ethics Committee (HREC) and local governance approvals
3. Training site staff

ANDA-L: Requirements for Participation

To participate in ANDA-L your diabetes centre must be able to meet the following criteria:

• Ability to nominate a PI to oversee and manage local data collection
• Ability to establish and maintain internal systems for data accuracy and timely data entry
• Willingness to comply with the project protocol and HREC requirements
• Willingness to sign an ANDA-L Collaborative Agreement